the aid library

LIST OPTIONS

Filter

15150

Care of girls and women living with female genital mutilation

World Health Organization WHO (2018) C_WHO

This handbook is for health care providers involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This includes obstetricians and gynaecologists, surgeons, general medical practitioners, midwives, nurses and other country-specific health profe... more

Download (589)

View PDF (784)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (611)

View PDF (635)

The impact of myopia and high myopia

World Health Organization (WHO) (2017) C_WHO

Report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on Myopia | University of New South Wales, Sydney, Australia 16–18 March 2015

Download (292)

View PDF (379)

Ghana - Country Cooperation Strategy 2024 - 2028

World Health Organization WHO (2025) C_WHO

The development of the Country Cooperation Strategy (CCS) was based on a consultative and participatory process with strong commitment and support from the Ministry of Health of Ghana. The CCS draws on lessons from the implementation of the first, and second generation CCSs, the country focus strate... more

Download (460)

View PDF (759)

Информирование о рисках при чрезвычайных ситуациях в области общественного здравоохранения

World Health Organization WHO (2018) C_WHO

Руководство ВОЗ по политике и практике информирования о рисках при чрезвычайных ситуациях (ИРЧС)

Download (400)

View PDF (409)

Керівництво mhGAP: для ведення психічних, неврологічних розладів і розладів, пов'язаних зі вживанням психоактивних речовин, у неспеціалізованих закладах охорони здоров'я
recommended

Tarun Dua, Nicolas Clark, Neerja Chowdhary et al. World Health Organisation (WHO) (2016) C_WHO

mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and... more

Download (573)

View PDF (530)

Promoting access to medical technologies and innovation, second edition, 30 August 2021

World Health Organization WHO and World Intellectual Property Organization WTO, WHO, WIPO (2021) CC

The second edition of the joint WHO, WIPO and WTO publication “Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade” (the Trilateral Study),* published in 2020, included a special insert mappi... more

Download (2025)

View PDF (2458)

Guidelines for essential trauma care
recommended

Mock, C et al World Health Organization (WHO) (2004) C_WHO

The Guidelines for essential trauma care seek to set achievable standards for trauma treatment services which could realistically be made available to almost every injured person in the world. They then seek to define the resources that would be necessary to assure such care. These include human res... more

Download (408)

View PDF (415)

Оцінка доступності основних лікарських засобів для амбулаторного лікування в Україні

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac... more

Download (439)

View PDF (668)

Towards UHC: thinking public

World Health Organisation (WHO) (2017) C_WHO

Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi... more

Download (243)

View PDF (449)

Eliminating Trachoma: Accelerating Towards 2020

World Health Organization WHO (2020) C_WHO

Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected tropical diseases (NTDs) that affect over one billion of the world’s poorest people.

Download (462)

View PDF (580)

Интеграция профилактики, лечения и ведения психических расстройств и других неинфекционных заболеваний в системе здравоохранения

World Health Organization WHO (2019) C_WHO

Психические расстройства имеют общие черты с другими неинфекционными заболеваниями, в том числе многие основные причины и общие последствия, высокую степень взаи... more

External Link (998)

Malawi contains cholera outbreak

World Health Organisation (WHO) (2023) C_WHO

Malawi's Ministry of Health officially declared on August 16, 2023, that the cholera outbreak is no longer a national health emergency. Since the outbreak began in February 2022, the country recorded 58,982 cholera cases and 1,768 deaths. Through coordinated efforts by the government, development pa... more

Download (364)

View PDF (228)

Sustainable financing: report of the Working Group - Report by the Director-General

Working Group on Sustainable Financing World Health Organization (WHO) (2022) CC

The Director-General has the honour to transmit to the Seventy-fifth World Health Assembly the report of the seventh meeting of the Working Group on Sustainable Financing, which met in a hybrid format, from 25 to 27 April 2022.

External Link

European inventory of national policies for the prevention of violence and injuries

World Health Organization WHO (2014) C_WHO

This inventory has been compiled by WHO/Europe to help facilitate monitoring and reporting of national policies for the prevention of violence and injuries, in close collaboration with national focal persons officially nominated by ministries of health and with support from the European Commission (... more

Download (210)

View PDF (318)

Elimination of Schistosomiasis

World Health Organization WHO (2012) C_WHO

SIXTY-FIFTH WORLD HEALTH ASSEMBLY WHA 65.21

External Link

Global snakebite burden Report by the Director-General

World Health Organization WHO (2018) C_WHO

Snakebite envenoming is a potentially life-threatening disease that typically results from the injection of a mixture of different toxins (“venom”) following the bite of a venomous snake. Envenoming can also be caused by venom being sprayed into a person’s eyes by certain species of snakes tha... more

Download (305)

View PDF (474)

First case of COVID-19 confirmed in the Democratic Republic of the Congo

World Health Organization WHO (2020) C_WHO

The Ministry of Public Health in the Democratic Republic of the Congo (DRC) has reported the country’s first case of COVID-19. Health authorities said tests found that a Congolese national, who had recently returned to Kinshasa from his residence in France had tested positive for the virus.

Guidelines for essential trauma care recommended

Guidelines for essential trauma care
recommended